Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2002 1
2003 1
2004 1
2006 1
2007 6
2008 4
2009 1
2010 3
2011 8
2012 10
2013 6
2014 7
2015 8
2016 7
2017 11
2018 8
2019 10
2020 12
2021 11
2022 8
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
Boucly A, Savale L, Jaïs X, Bauer F, Bergot E, Bertoletti L, Beurnier A, Bourdin A, Bouvaist H, Bulifon S, Chabanne C, Chaouat A, Cottin V, Dauphin C, Degano B, De Groote P, Favrolt N, Feng Y, Horeau-Langlard D, Jevnikar M, Jutant EM, Liang Z, Magro P, Mauran P, Moceri P, Mornex JF, Palat S, Parent F, Picard F, Pichon J, Poubeau P, Prévot G, Renard S, Reynaud-Gaubert M, Riou M, Roblot P, Sanchez O, Seferian A, Tromeur C, Weatherald J, Simonneau G, Montani D, Humbert M, Sitbon O. Boucly A, et al. Among authors: bergot e. Am J Respir Crit Care Med. 2021 Oct 1;204(7):842-854. doi: 10.1164/rccm.202009-3698OC. Am J Respir Crit Care Med. 2021. PMID: 34185620 Free article.
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.
Guignabert C, Savale L, Boucly A, Thuillet R, Tu L, Ottaviani M, Rhodes CJ, De Groote P, Prévot G, Bergot E, Bourdin A, Howard LS, Fadel E, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Sitbon O, Humbert M. Guignabert C, et al. Among authors: bergot e. Circulation. 2023 Jun 13;147(24):1809-1822. doi: 10.1161/CIRCULATIONAHA.122.061501. Epub 2023 Apr 25. Circulation. 2023. PMID: 37096577
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H; EXAFIP investigators and the OrphaLung network. Naccache JM, et al. Among authors: bergot e. Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7. Lancet Respir Med. 2022. PMID: 34506761 Clinical Trial.
Sarcoidosis.
Bergot E, Paparel P, Zalcman G. Bergot E, et al. N Engl J Med. 2008 Mar 27;358(13):1404; author reply 1404-5. N Engl J Med. 2008. PMID: 18376441 No abstract available.
Cytokines as prognostic biomarkers in pulmonary arterial hypertension.
Boucly A, Tu L, Guignabert C, Rhodes C, De Groote P, Prévot G, Bergot E, Bourdin A, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Humbert M, Sitbon O, Savale L. Boucly A, et al. Among authors: bergot e. Eur Respir J. 2023 Mar 23;61(3):2201232. doi: 10.1183/13993003.01232-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36549710
Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort.
Mabo A, Borie R, Wemeau-Stervinou L, Uzunhan Y, Gomez E, Prevot G, Reynaud-Gaubert M, Traclet J, Bergot E, Cadranel J, Marchand-Adam S, Bergeron A, Blanchard E, Bondue B, Bonniaud P, Bourdin A, Burgel PR, Hirschi S, Marquette CH, Quétant S, Nunes H, Chenivesse C, Crestani B, Guirriec Y, Monnier D, Ménard C, Tattevin P, Cottin V, Luque Paz D, Jouneau S; OrphaLung Network. Mabo A, et al. Among authors: bergot e. Thorax. 2023 Dec 15;79(1):68-74. doi: 10.1136/thorax-2023-220040. Thorax. 2023. PMID: 37758458 Free article.
Pulmonary complications of type 1 neurofibromatosis.
Reviron-Rabec L, Girerd B, Seferian A, Campbell K, Brosseau S, Bergot E, Humbert M, Zalcman G, Montani D. Reviron-Rabec L, et al. Among authors: bergot e. Rev Mal Respir. 2016 Jun;33(6):460-73. doi: 10.1016/j.rmr.2014.09.010. Epub 2016 Feb 8. Rev Mal Respir. 2016. PMID: 26868668 Review.
Neurological involvement in hereditary hemorrhagic telangiectasia.
Labeyrie PE, Courthéoux P, Babin E, Bergot E, Touzé E, Pelage JP. Labeyrie PE, et al. Among authors: bergot e. J Neuroradiol. 2016 Jul;43(4):236-45. doi: 10.1016/j.neurad.2016.02.005. Epub 2016 Apr 5. J Neuroradiol. 2016. PMID: 27059009 Review.
[About atypic tissular mass].
Guimas M, Le Palud P, Bergot E. Guimas M, et al. Among authors: bergot e. Rev Pneumol Clin. 2018 Apr;74(2):115-117. doi: 10.1016/j.pneumo.2018.01.001. Rev Pneumol Clin. 2018. PMID: 29402487 French. No abstract available.
126 results